Study to Assess the PK Profile of NanoBUP Capsules Relative to Suboxone
NCT01260675 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12
Last updated 2017-06-23
Summary
Phase 1 study to determine the pharmacokinetic profile of NanoBUP Capsules to Suboxone.
Conditions
- Healthy
Interventions
- DRUG
-
Buprenorphine HCl/Naloxone HCl
Sponsors & Collaborators
-
NanoSHIFT LLC
lead INDUSTRY
Principal Investigators
-
Michael Natalino, MD · Worldwide Clinical Trials
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-12-31
- Primary Completion
- 2011-01-31
- Completion
- 2011-01-31
Countries
- United States
Study Locations
More Related Trials
-
Novel Induction to Buprenorphine/Naloxone
NCT05644587 ·Status: TERMINATED ·Phase: PHASE4
-
Abuse Liability of Suboxone Versus Subutex
NCT00710385 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Tolerability of Buprenorphine/Naloxone Film Strips
NCT00640835 ·Status: COMPLETED ·Phase: PHASE2
-
Preference for Subutex® (Buprenorphine) Versus Suboxone® (Buprenorphine/Naloxone) in Opioid Dependent Patients on Subutex® (Study P05094)(COMPLETED)
NCT00684073 ·Status: COMPLETED ·Phase: PHASE4
-
Determine the Safety of a Sublingual Tablet Formulation of Buprenorphine and Naloxone by Extending the Combination Tablet Availability to Physicians in Office-Based Practice
NCT00007527 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Buprenorphine/Naloxone With Naltrexone in Opioid Dependent Adolescents
NCT01015066 ·Status: WITHDRAWN ·Phase: PHASE4
-
Buprenorphine Naltrexone-P1 A-Cocaine
NCT00733720 ·Status: COMPLETED ·Phase: PHASE1
-
A Bioavailability and Safety Study of Probuphine Versus Sublingual Buprenorphine in Patients With Opioid Dependence
NCT00768482 ·Status: TERMINATED ·Phase: PHASE3
-
Trial of Buprenorphine/Naloxone for Opiate Dependence - 2
NCT00000353 ·Status: COMPLETED ·Phase: PHASE2
-
Single Dose Pharmacokinetics of Suboxone Study in Hepatic Impaired Subjects
NCT01846455 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetics (PK) and Safety of Multiple Doses of Intranasal Naloxone in Healthy Adults
NCT05377255 ·Status: COMPLETED ·Phase: PHASE1
-
Buprenorphine/Naloxone for Treatment of Opiate Dependence - 9
NCT00000344 ·Status: COMPLETED ·Phase: PHASE2
-
Multicentre Trial of Suboxone in Opiate-dependent Subjects in Taiwan
NCT00901875 ·Status: COMPLETED ·Phase: PHASE4
-
Blockade Efficacy of Buprenorphine/Naloxone For Opioid Dependence
NCT00134888 ·Status: COMPLETED ·Phase: NA
-
Study of a Novel Subcutaneous Depot Formulation of Buprenorphine
NCT03715634 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacodynamic Evaluation of Intramuscular Nalmefene Autoinjector 1.5 mg Compared to Intranasal Narcan 4 mg
NCT06719986 ·Status: COMPLETED ·Phase: PHASE1
-
Buprenorphine and Naloxone for the Treatment of Opiate Dependence - 1
NCT00015171 ·Status: COMPLETED ·Phase: PHASE3
-
Usability of Zubsolv Sublingual Tablets 5.7/1.4 to Suboxone Sublingual Film 8/2 In Buprenorphine/Naloxone Treated Opioid Dependent Population
NCT02038790 ·Status: COMPLETED ·Phase: PHASE4
-
Buprenorphine/Naloxone - Facilitated Rehabilitation for Opioid Dependent Adolescents - 1
NCT00078130 ·Status: COMPLETED ·Phase: PHASE3
-
Multiple Dose Pharmacokinetics Depot Buprenorphine in Opioid-Dependent Subjects
NCT01738503 ·Status: COMPLETED ·Phase: PHASE2
-
Buprenorphine/Naloxone for Opiate-Dependence Treatment - 1
NCT00015028 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Intranasal Naltrexone and Naloxone
NCT03851731 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Adult Outpatients With Opioid Dependence Transitioned From a Daily SL Buprenorphine to Probuphine® Subdermal Implants
NCT02180659 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Drug-drug Interaction of BMS 663068 With Methadone and Also With Buprenorphine/Naloxone
NCT02666001 ·Status: COMPLETED ·Phase: PHASE1
-
Treatment of Opioid Dependent Patients With Suboxone: Acceptability & Safety Data From Real Life Scenario (Study P05603)
NCT00723749 ·Status: COMPLETED